Symposia

« Back

Print this page

	Personalized Program The Personalized Program enables you to compile an individual program with events and contributions of your interest. Therefore, it can be used very well to plan your actual congress visit at an early point of time. Please log in to use the Personalized Program.	» Login » Identification » Help

	Sunday, 28. June 2009	next day »

No.	S-01 - Symposium
Time:	08.00-09.30
Room:	Blue Amphitheatre
Topic:	Genetics
Track:	1 Basic
Session title:	Genetic strategies in the search for genes in schizophrenia
	Florence Thibaut, France	Chair
	Norio Ozaki, Japan	Co-Chair

001	DISC 1 interacting molecule and schizophrenia
	Norio Ozaki, Japan	Speaker
002	Genetic findings in schizophrenia and related intermediate phenotypes: New genes and pathways
	Dan Rujescu, Germany	Speaker
003	CAPON gene in schizophrenic Latin America population
	Jorge Ospina-Duque, Colombia	Speaker
004	Cognition guided genetics of schizophrenia
	Rainald Mössner, Germany	Speaker

No.	S-02 - Symposium
Time:	08.00-09.30
Room:	Salle Maillot
Topic:	Affective Disorders (Bipolar)
Track:	1 Basic
Session title:	Comparative neuropathology of schizophrenia and bipolar disorder
	Bernhard Bogerts, Germany	Chair
	Sabine Bahn, United Kingdom	Co-Chair

001	Peripheral biomarkers as indicators of brain pathology in schizophrenia and affective disorder
	Sabine Bahn, United Kingdom	Speaker
002	White matter abnormalities in schizophrenia and bipolar disorder
	Andrew Dwork, USA	Speaker
003	Immunohistochemical studies in schizophrenia and bipolar disorder
	Bernhard Bogerts, Germany	Speaker
004	Ultrastructural studies in schizophrenia and bipolar disorder
	Natalia Uranova, Russia	Speaker

No.	S-03 - Symposium
Time:	08.00-09.30
Room:	Room 352AB
Topic:	Psychotic Disorders
Track:	1 Basic
Session title:	Serotonin receptors in endophenotypic variations and treatment of schizophrenia: Genetic, neurocognitive, and pharmacological perspectives
	Tomiki Sumiyoshi, Japan	Chair
	Vera Bubenikova-Valesova, Czech Republic	Co-Chair

001	Multimodal imaging genetics on serotonin receptor polymorphisms in schizophrenia
	Jiri Horacek, Czech Republic	Speaker
002	Improving cognitive function in animal models of schizophrenia: Focus on serotonin receptors
	Vera Bubenikova-Valesova, Czech Republic	Speaker
003	Learning and memory in 5-HT1A-receptor mutant mice
	Bettina Bert, Germany	Speaker
004	Serotonin-1A receptors and cognitive enhancement in schizophrenia: Evidence from translational research
	Tomiki Sumiyoshi, Japan	Speaker

No.	S-04 - Symposium
Time:	08.00-09.30
Room:	Room 252B
Topic:	Brain Function
Track:	1 Basic
Session title:	Social brain functions in schizophrenia and mood disorders
	Shigenobu Kanba, Japan	Chair
	Martin Brüne, Germany	Co-Chair

001	Charcterization of epathy deficits in psychiatric populations
	Simone Shamay-Tsoory, Israel	Speaker
002	Deficit in theory of mind predicts treatment outcome of depression
	Shigenobu Kanba, Japan	Speaker
003	Integrated approach of theory of mind and contextual processing deficits in schizophrenia: from neurocognitive deficits to clinical assessment
	Eric Brunet-Gouet, France	Speaker
004	Social cognition and deviant behavior in schizophrenia
	Martin Brüne, Germany	Speaker

No.	S-05 - Symposium
Time:	08.00-09.30
Room:	Room 241
Topic:	Neuroimaging
Track:	3 Interface
Session title:	Near-infrared spectroscopy (NIRS) in psychiatry: Current status and future prospect
	Masato Fukuda, Japan	Chair
	Andreas J. Fallgatter, Germany	Co-Chair

001	Bilateral frontal activation during a phonological working memory task in schizophrenic patients
	Sohee Park, USA	Speaker
002	Near-infrared spectroscopy in mood disorders
	Masato Fukuda, Japan	Speaker
003	NIRS in Attention-Deficit / Hyperactivity Disorder (ADHD)
	Andreas J. Fallgatter, Germany	Speaker
004	Clinical NIRS application to psychiatric diagnosis and evaluation
	Ryu Takizawa, Japan	Speaker

No.	S-06 - Symposium
Time:	08.00-09.30
Room:	Room 251
Topic:	Psychopharmacology
Track:	1 Basic
Session title:	The endocannabinoid system in psychiatric disorders: From basic neuroscience to clinical practice
	F. Markus Leweke, Germany	Chair
	Daniele Piomelli, Italy	Co-Chair

001	Breakdown of cell assembly synchronization by CB1 receptor activation
	György Buzsaki, Hungary	Speaker
002	Endocannabinoids in anxiety and depression
	Daniele Piomelli, Italy	Speaker
003	eCB, processing reward-related stimuli and substance use disorders
	Rajita Sinha, USA	Speaker
004	Translational studies on eCBs in schizophrenia: Bench to bedside
	F. Markus Leweke, Germany	Speaker

No.	S-07 - Symposium
Time:	11.00-12.30
Room:	Blue Amphitheatre
Topic:	Genetics
Track:	1 Basic
Session title:	Gene-environment interactions in mental health: New paradigms in basic and clinical research
	Mikhail Pletnikov, USA	Chair
	Jim van Os, Netherlands	Co-Chair

001	How to model the environment in human GxE studies of psychosis
	Jim van Os, Netherlands	Speaker
002	Human G x E interactions in depression using experimental ecogenetic approaches
	Marieke Wichers, Netherlands	Speaker
003	Gene-environment interactions throughout development: Adaptability and resilience in monkey model
	Stephen Suomi, USA	Speaker
004	Gene-environment interactions in psychiatry: DISC1 mouse model
	Mikhail Pletnikov, USA	Speaker

No.	S-08 - Symposium
Time:	11.00-12.30
Room:	Salle Maillot
Topic:	Psychopharmacology
Track:	1 Basic
Session title:	Non-classical mechanisms of action of antidepressants
	Rainer Rupprecht, Germany	Chair
	Mark Rasenick, USA	Co-Chair

001	Role of lipid rafts for antidepressant induced G-protein signalling
	Mark Rasenick, USA	Speaker
002	Modulation of ligand-gated ion channels by antidepressants
	Rainer Rupprecht, Germany	Speaker
003	Role of P-glycoprotein for HPA axis activity and antidepressant treatment
	Carmine Pariante, United Kingdom	Speaker
004	5-HT6 receptor stimulation regulates excitatory and inhibitory neurotransmission and induces neuronal plasticity: Potential mechanisms for antidepressant drug action and neuroprotection
	Lee Schechter, USA	Speaker

No.	S-09 - Symposium
Time:	11.00-12.30
Room:	Room 352AB
Topic:	Anxiety
Track:	1 Basic
Session title:	Glutamate as a neurobiological target in anxiety disorders: Metabotropic or ionotropic receptors?
	Brian Harvey, South Africa	Chair
	Mohammed Shahid, United Kingdom	Co-Chair

001	Role of the glutamate system in the neurobiology of anxiety and stress related disorders: How strong is the therapeutic rationale?
	S.J. Mathew, USA	Speaker
002	Role of animal models in the development of current and novel therapeutic strategies for anxiety disorders
	John Cryan, Ireland	Speaker
003	Targeting metabotropic glutamate receptors: Evidence to support pharmacological validation in anxiety and stress disorders
	Andrzej Pilc, Poland	Speaker
004	Targeting ionotropic glutamate receptors: Therapeutic rationale in anxiety and stress disorders
	Wojciech Danysz, Germany	Speaker

No.	S-10 - Symposium
Time:	11.00-12.30
Room:	Room 252B
Topic:	Psychotic Disorders
Track:	1 Basic
Session title:	Disturbed synaptic plasticity in schizophrenia? The evidence, visualisation and modulation.
	William G. Honer, Canada	Chair
	Peter Falkai, Germany	Co-Chair

001	How good is the evidence from post-mortem studies?
	William G. Honer, Canada	Speaker
002	Using in-vivo imaging: Can we see synaptic processes directly?
	Gunther Helms, Germany	Speaker
003	NRG-1, synaptic processes and schizophrenia
	Stephen Lawrie, United Kingdom	Speaker
004	Enhancing synaptic processes via exercise? Is there evidence for schizophrenia?
	Frank-Gerald Pajonk, Germany	Speaker

No.	S-11 - Symposium
Time:	11.00-12.30
Room:	Room 241
Topic:	Affective Disorders (Bipolar)
Track:	1 Basic
Session title:	Vigilance regulation in affective disorders
	Ulrich Hegerl, Germany	Chair
	Nathalie Besnier, France	Co-Chair

001	Is mania an autoregulatory attempt to stabilize vigilance and are psychostimulants a treatment option?
	Peter Schönknecht, Germany	Speaker
002	Excessive daytime sleepiness: The role of anxiety, insomnia and depression
	Gregor Hasler, Switzerland	Speaker
003	Vigilance and cognition in bipolar affective disorders
	Nathalie Besnier, France	Speaker
004	Sleep disturbances in patients with affective disorders
	Goeran Hajak, Germany	Speaker

No.	S-12 - Symposium
Time:	11.00-12.30
Room:	Room 251
Topic:	Other
Track:	1 Basic
Session title:	Impulse disorders - categorical versus dimensional approaches: State of the evidence
	Larry Siever, USA	Chair
	Franck Bayle, France	Co-Chair

001	Fractionating impulsivity: Neural and neurochemical perspectives
	Trevor Robbins, United Kingdom	Speaker
002	Brain circuitry and neuromodulators in impulsive aggressive personality disorders
	Larry Siever, USA	Speaker
003	Functional neurocircuitry and neuropsychopharmacology of pathological gambling and the ICD's
	Eric Hollander, USA	Speaker
004	Is ADHD the prototypical impulse control disorder or impulsive facet in ADHD a semantic mistake: Clinical and neuropsychological arguments
	Franck Bayle, France	Speaker

No.	S-13 - Symposium
Time:	14.00-15.30
Room:	Blue Amphitheatre
Topic:	Brain Function
Track:	3 Interface
Session title:	Translational neuroscience: Do we learn anything for psychiatric practice?
	Dieter F. Braus, Germany	Chair
	Gabriele Sachs, Austria	Co-Chair

001	Neuroimaging in psychiatry
	Dieter F. Braus, Germany	Speaker
002	Sensorimotor gating and the tale of the prediction of antipsychotic effects
	Boris Quednow, Switzerland	Speaker
003	Biomarkers of affective disorders
	Lukas Pezawas, Austria	Speaker
004	Neurobiology of psychotherapy
	Gabriele Sachs, Austria	Speaker

No.	S-14 - Symposium
Time:	14.00-15.30
Room:	Salle Maillot
Topic:	Other
Track:	1 Basic
Session title:	Psychiatric disorders and thyroid axis functioning across lifecycles
	Robertas Bunevicius, Lithuania	Chair
	Peter Whybrow, USA	Co-Chair

001	Thyroid and developing brain
	Victor Pop, Netherlands	Speaker
002	Thyroid hormones in treatment of mood disorders
	Michael Bauer, Germany	Speaker
003	PMDD and thyroid functioning
	Susan Girdler, USA	Speaker
004	Thyroid functioning and mental disorders
	Robertas Bunevicius, Lithuania	Speaker

No.	S-15 - Symposium
Time:	14.00-15.30
Room:	Room 352AB
Topic:	Affective Disorders (Unipolar)
Track:	2 Clinical
Session title:	Brain-focussed treatments of depression
	Klaus Ebmeier, United Kingdom	Chair
	Thomas Schlaepfer, Germany	Co-Chair

001	New data on the mode of action of electroconvulsive therapy
	Allan Scott, United Kingdom	Speaker
002	New data on efficacy and safety of magnetic seizure therapy
	Mustafa Husain, USA	Speaker
003	New methodological developments in transcranial magnetic stimulation
	John Rothwell, United Kingdom	Speaker
004	New data on deep brain stimulation
	Thomas Schlaepfer, Germany	Speaker

No.	S-16 - Symposium
Time:	14.00-15.30
Room:	Room 252B
Topic:	Neuroimaging
Track:	1 Basic
Session title:	Advances in the neuroimaging of ADHD
	Joseph Biederman, USA	Chair
	Larry Seidman, USA	Co-Chair

001	Neuroimaging findings implicating fronto-cerebellar circuit abnormalities in the pathophysiology of ADHD
	Eve Valera, USA	Speaker
002	Frontal lobe cortical-limbic deficiencies in adults with ADHD comorbid with bipolar disorder: A cortical thickness MRI analysis
	Nikos Makris, USA	Speaker
003	Pharmacoimaging studies of stimulant formulations in ADHD using positron emission tomography
	Thomas Spencer, USA	Speaker
004	Genetic imaging as a method for identifying pathophysiological heterogeneity in psychiatric disorders: Evidence from ADHD
	Larry Seidman, USA	Speaker

No.	S-17 - Symposium
Time:	14.00-15.30
Room:	Room 241
Topic:	Anxiety
Track:	3 Interface
Session title:	Translational neuroscience may inform treatment development for posttraumatic stress disorder
	Leo Sher, USA	Chair
	Alexander Neumeister, USA	Co-Chair

001	Early postnatal stress: Impact on neural circuits and relevance to psychophysiology
	Machiko Matsumoto, Japan	Speaker
002	Long term alterations in brain and neurobiology in PTSD
	Eric Vermetten, Netherlands	Speaker
003	Mechanisms of resilience: Lessons from PET imaging
	Alexander Neumeister, USA	Speaker
004	Neurobiology of suicidal behavior in PTSD and implications for suicide prevention
	Leo Sher, USA	Speaker

No.	S-18 - Symposium
Time:	14.00-15.30
Room:	Room 251
Topic:	Genetics
Track:	3 Interface
Session title:	Neurosciences of suicidal behaviour: New targets for prevention?
	Philippe Courtet, France	Chair
	Alec Roy, France	Co-Chair

001	What genes tell us - ethical perspectives
	Alain Malafosse, Switzerland	Speaker
002	Will emotional and cognitive endophenotypes provide new therapeutic targets?
	Philippe Courtet, France	Speaker
003	Predictive value of genetic findings: New analytical methods
	Enrique Baca Garcia, Spain	Speaker
004	Suicide risk in prisoners: Genes environment interactions
	Marco Sarchiapone, Italy	Speaker

No.	S-19 - Symposium
Time:	14.00-15.30
Room:	Room 351
Topic:	Neurodegenerative Disorders
Track:	2 Clinical
Session title:	Early diagnosis of Alzheimers disease
	Bruno Dubois, France	Chair
	Harald Hampel, Germany	Co-Chair

001	Clinical and prognostic heterogeneity of mild cognitive impairment
	Orestes V. Forlenza, Brazil	Speaker
002	The role CSF biomarkers in the identification of AD at pre-dementia stages
	Harald Hampel, Germany	Speaker
003	Imaging of amyloid-beta in Alzheimers disease
	Swen Hesse, Germany	Speaker
004	For a new concept and new criteria for the diagnosis of Alzheimer’s disease
	Bruno Dubois, France	Speaker

No.	S-20 - Symposium
Time:	16.00-17.30
Room:	Blue Amphitheatre
Topic:	Brain Function
Track:	3 Interface
Session title:	Deep brain stimulation in repetitive behaviors
	Luc Mallet, France	Chair
	Paul Cosyns, Belgium	Co-Chair

001	Ventral capsule/ventral striatum stimulation in obsessive-compulsive disorder
	Benjamin Greenberg, USA	Speaker
002	Anatomical correlates of deep brain stimulation efficacy in obsessive compulsive disorder
	Leos Gabriels, Belgium	Speaker
003	Deep brain stimulation of the nucleus accumbens for therapy-refractory obsessive-compulsive disorder
	Damiaan Denys, Netherlands	Speaker
004	Effect of stimulation of limbic relays in basal ganglia on tics and compulsions
	Marie-Laure Welter, France	Speaker

No.	S-21 - Symposium
Time:	16.00-17.30
Room:	Salle Maillot
Topic:	Affective Disorders (Unipolar)
Track:	1 Basic
Session title:	Social cognition in depression and suicide: A neuroimaging perspective
	Jonathan Roiser, France	Chair
	Philippe Fossati, France	Co-Chair

001	Self perception in depressed patients and subjects with high risk for depression
	Philippe Fossati, France	Speaker
002	Neural circuits underlying anhedonia in major depressive disorder
	Jonathan Roiser, France	Speaker
003	Is suicide a specific disorder of social cognition?
	Fabrice Jollant, France	Speaker
004	Emotional and social memory
	Martin Lepage, Canada	Speaker

No.	S-22 - Symposium
Time:	16.00-17.30
Room:	Room 352AB
Topic:	Affective Disorders (Bipolar)
Track:	2 Clinical
Session title:	Suicide prevention: Focusing on modifiable risk factors
	Zoltan Rihmer, Hungary	Chair
	Hagop S. Akiskal, USA	Co-Chair

001	Prophylaxis of bipolar disorder
	Leonardo Tondo, USA	Speaker
002	Treatment of depression
	Zoltan Rihmer, Hungary	Speaker
003	Are sudden dips in mood the final common pathway of suicide?
	Hagop S. Akiskal, USA	Speaker
004	Are any of the biological substrates of suicidality modifiable?
	Leo Sher, USA	Speaker

No.	S-23 - Symposium
Time:	16.00-17.30
Room:	Room 252B
Topic:	Addictive Disorders
Track:	3 Interface
Session title:	Are first experiences with alcohol predicting later risk of alcohol-dependence? Clinical and biological approaches
	Pierre-Marie Llorca, France	Chair
	Wei J. Chenb, Taiwan	Co-Chair

001	Alcohol consumption and dependence: A study of medical students
	Sami Richa, Lebanon	Speaker
002	Early alcohol experiences and adolescent mental health: A population-based study in Taiwan
	Wei J. Chenb, Taiwan	Speaker
003	Alcohol initiation experiences and family history of alcoholism as predictors of problem-drinking trajectories
	Warner La, USA	Speaker

No.	S-24 - Symposium
Time:	16.00-17.30
Room:	Room 241
Topic:	Childhood Adolescent Disorder
Track:	3 Interface
Session title:	The possible role of Oxytocin as a key molecule in the new treatment and in the pathogenesis of autism-spectrum disorder
	Nobumasa Kato, Japan	Chair
	Michael Lombardo, United Kingdom	Co-Chair

001	Introduction
	Nobumasa Kato, Japan	Speaker
002	Possible animal model of autism
	Haruhiro Higashida, Japan	Speaker
003	Neuroimage of autism: Neural basis of oxytocin
	Hidenori Yamasue, Japan	Speaker
004	Neural correlates of social cognition
	Michael Lombardo, United Kingdom	Speaker

No.	S-25 - Symposium
Time:	16.00-17.30
Room:	Room 251
Topic:	Anxiety
Track:	3 Interface
Session title:	Peripheral and central mechanisms involved in post-traumatic stress disorder and its treatment
	Stephanie Khalfa, France	Chair
	Tanja Michael, Switzerland	Co-Chair

001	Translational research in the neuroscience of fear extinction: Implications to PTSD and other anxiety disorders
	Mohammed R. Milad, USA	Speaker
002	Variability of symptoms in daily life of patients with PTSD
	Tanja Michael, Switzerland	Speaker
003	Update on biopsychological correlates and predispositions of PTSD and its successful CBT treatment
	Anke Karl, United Kingdom	Speaker
004	Fear conditioning/extinction in PTSD before and after treatment
	Stephanie Khalfa, France	Speaker

Sunday, 28. June 2009

next day »